BEVACIZUMAB

Clinical trials for BEVACIZUMAB explained in plain language.

Never miss a new study

Get alerted when new BEVACIZUMAB trials appear

Sign up with your email to follow new studies for BEVACIZUMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 2 Completed 1

New combo therapy shows promise for untreatable liver cancer

Disease control Not yet recruiting

This study tests a new drug combination for people with advanced liver cancer that cannot be surgically removed. Participants will receive two immunotherapy drugs (adebrelimab and low-dose bevacizumab) along with a two-step procedure that delivers chemotherapy directly to the liv…

Matched conditions: BEVACIZUMAB

Phase: PHASE2 • Sponsor: Third Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control

Last updated May 15, 2026 11:54 UTC

BEVACIZUMAB

Get alerted when new BEVACIZUMAB trials appear

New combo therapy shows promise for untreatable liver cancer